Skip to main content

Chemoprophylaxis of Meningococcal Meningitis

  • Chapter
  • 86 Accesses

Abstract

There are primarily two situations where the question of prophylaxis against meningococcal disease is raised, first the community epidemic and second, for close contacts of patients with meningococcal meningitis or meningococcemia.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gotschlich, E. C., Goldschneider, I. and Artenstein, M. S.: Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J. Exp. Med. 129:1367–1384, 1969.

    Article  PubMed  CAS  Google Scholar 

  2. Guttler, R. B., Counts, G. W., Avent, C. K. and Beaty, H. N.: Effect of rifampin and minocycline on meningococcal carrier rates. J. Infect. Dis. 124(2):199–205, Aug. 1971.

    Article  PubMed  CAS  Google Scholar 

  3. Munford, R. S., Vasconcelos de, Z. J. S., Phillips, C. J., et al.: Eradication of carriage of Neisseria meningitidis in families: A study in Brazil. J. Infect. Dis. 129(6): 644–649, June 1974.

    Article  PubMed  CAS  Google Scholar 

  4. Bennett, J. V., Camp, H. M. and Eickhoff, T. C: Rapid sulfonamide disc sensitivity test for meningococi. Appl. Microbiol. 16:1056–1060, 1968.

    PubMed  CAS  Google Scholar 

  5. Center for Disease Control. Morbidity and Mortality Weekly Report 24(6):55–56, 8 Feb. 1975.

    Google Scholar 

  6. Eickhoff, T. C. In vitro and in vivo studies of resistance to rifampin in meningococci. J. Infect. Dis. 123:414–420, Apr. 1971.

    Article  PubMed  CAS  Google Scholar 

  7. Kaiser, A. B., Hennekans, C. H., Saslaw, M. S., et al.: Seroepidemiology and chemoprophylaxis of disease due to sulfonamide-resistant Neisseria meningitidis in a civilian population. J. Infect. Dis. 130:217–224, 1974.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1976 Plenum Press, New York

About this chapter

Cite this chapter

Tramont, E.C., Artenstein, M.S. (1976). Chemoprophylaxis of Meningococcal Meningitis. In: Williams, J.D., Geddes, A.M. (eds) Chemotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4346-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-4346-2_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4348-6

  • Online ISBN: 978-1-4613-4346-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics